Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

DEVON, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences.

Armando Anido
, Chairman and CEO, will present at the Jefferies London Healthcare Conference in London, UK, on November 17, 2016 at 2:00 pm GMT.

Jim Fickenscher
, CFO and VP Corporate Development, will present at the Stifel 2016 Healthcare Conference in New York City on November 16, 2016 at 1:30 pm ET.  Mr. Fickenscher will be joined by Donna Gutterman
, PharmD, VP Medical, in participation at the Maxim Group Central Nervous Disease Conference in New York City on November 17, 2016. 

To listen to a webcast of the Jefferies or Stifel presentations live, please visit the Investor Relations page

... read more at: http://www.nasdaq.com/press-release/zynerba-pharmaceuticals-to-participate-in-upcoming-investor-conferences-20161109-00307